Hazard ratios also were lower in the immunotherapy than in the control group for all-cause death ( 0.21 ; 95 % CI , 0.06-0 .75 ; P = .008 ) and cancer-related death ( 0.19 ; 95 % CI , 0.04-0 .87 ; P = .02 ) .